Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis

An association between liver stiffness, a surrogate measure of liver fibrosis, and chronic kidney disease (CKD) in patients with nonalcoholic fatty liver disease (NAFLD) has been proposed. However, most studies were small and had low statistical power. We systematically searched PubMed-MEDLINE and Scopus from inception to August 2021 for cross-sectional or cohort studies reporting the association between liver stiffness diagnosed by vibration controlled transient elastography (VCTE) and renal dysfunction. The primary outcome was CKD, defined as a composite of urinary albumin to creatinine ratio (UACR) >= 30 mg/g and estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2). Measures of association from individual studies were meta-analyzed using random effects models. Of the 526 titles initially scrutinized, 7 cross-sectional studies fulfilled the criteria and were included. For CKD, risk was higher in patients with liver fibrosis assessed by VCTE, compared with patients without (n = 5 studies: OR 2.49, 95% CI 1.89-3.29; test for overall effect z = 6.475, p < 0.001). When increased UACR was considered as an outcome, elevated liver stiffness was associated with a significantly increased risk as well (n = 3 studies: OR 1. 98 95% CI 1.29-3.05; test for overall effect z = 3.113, p = 0.002). Neither analysis showed significant heterogeneity (I-2 = 0% and I-2 = 46.5%, respectively for the two outcomes). This meta-analysis indicates that elevated liver stiffness is associated with increased odds of kidney outcomes among patients with NAFLD. Wider use of VCTE to screen for advanced fibrosis might help identify patients at risk of end-stage renal disease.

Automated summary

This meta-analysis examines the association between liver stiffness and chronic kidney disease (CKD) in patients with nonalcoholic fatty liver disease (NAFLD). The results show that patients with liver fibrosis assessed by vibration controlled transient elastography (VCTE) have a higher risk of CKD compared to those without liver fibrosis. Elevated liver stiffness is also significantly associated with increased risk of higher urinary albumin to creatinine ratio (UACR). The findings suggest that wider use of VCTE to screen for advanced fibrosis may help identify patients at risk of kidney damage.